Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) is one of the Best 52-Week Low Stocks to Buy According to Analysts.

A discovery with major implications for cancer treatment has been made by a team of researchers from Rensselaer Polytechnic ...

Trump said late Tuesday his administration will begin implementing pharmaceutical tariffs next month, making good on months of threats.